Recently, advances in synthetic biology have allowed us to perform more advanced systems metabolic engineering by creating novel biological systems, empowering microorganisms to gain new metabolic capabilities, which they otherwise might not have obtained naturally.
Recently, advances in implant macrodesign [ 6– 8] as well as technical advancement [ 9– 11] have limited the need for grafting procedures.
Recently advances have plummeted for all writers but the literary community has taken a larger hit (in the light of the new sales information the only way to justify spending big bucks is if a book is assured big sales).
Recently, advances in direct cell lineage conversion have suggested a potential solution to these issues.
Recently, advances in field-programmable technology spark renewed interest in dataflow systems.
Recently, advances have been made in understanding RR functions both at genome-wide and molecular levels.
Recently, advances in imaging and image-analysis methodologies have accelerated large-scale perturbation screens.
More recently, advances in automated synthesis of chemicals allow millions of chemicals to be synthesized by a single organization.
Recently, advances of examination such as imaging and endoscopy are increasing small intestinal adenocarcinoma in a proper diagnostic rate.
Recently, advances in the supercapacitor (SC) have made the SC and battery hybrid energy storage systems (HESS) technically attractive.
Recently, advances have been made in the design of peptide systems with autocatalytic and cross-catalytic properties.
